ALNYLAM PHARMACEUTICALS, INC.

MA

Pharmaceutical manufacturer

Filings
13
Firms Hired
1
Total Expenses
$4,680,000
Years Active
2023–2026

Filings

All 2026202520242023
YearFirmPeriodExpensesDoc
2026 ALNYLAM PHARMACEUTICALS, INC. 2nd Quarter (Apr 1 - June 30)
2nd Quarter - Report 		$450,000
2026 ALNYLAM PHARMACEUTICALS, INC. 1st Quarter (Jan 1 - Mar 31)
1st Quarter - Report 		$430,000
2025 ALNYLAM PHARMACEUTICALS, INC. 4th Quarter (Oct 1 - Dec 31)
4th Quarter - Report 		$390,000
2025 ALNYLAM PHARMACEUTICALS, INC. 3rd Quarter (July 1 - Sep 30)
3rd Quarter - Report 		$390,000
2025 ALNYLAM PHARMACEUTICALS, INC. 2nd Quarter (Apr 1 - June 30)
2nd Quarter - Report 		$390,000
2025 ALNYLAM PHARMACEUTICALS, INC. 1st Quarter (Jan 1 - Mar 31)
1st Quarter - Report 		$440,000
2024 ALNYLAM PHARMACEUTICALS, INC. 4th Quarter (Oct 1 - Dec 31)
4th Quarter - Report 		$500,000
2024 ALNYLAM PHARMACEUTICALS, INC. 3rd Quarter (July 1 - Sep 30)
3rd Quarter - Report 		$480,000
2024 ALNYLAM PHARMACEUTICALS, INC. 2nd Quarter (Apr 1 - June 30)
2nd Quarter - Report 		$480,000
2024 ALNYLAM PHARMACEUTICALS, INC. 1st Quarter (Jan 1 - Mar 31)
1st Quarter - Report 		$290,000
Page 1 of 2  ·  13 filings Next
Firms Hired
FirmFilingsExpenses
ALNYLAM PHARMACEUTICALS, INC. 13 $4,680,000
Issue Areas
IssueActivities
Medicare/Medicaid 12
Trade (domestic/foreign) 5
Pharmacy 5
Veterans 4

Bills Mentioned in Filings

HR.4993 HR1672 H.R. 5397 H.R. 5547 H.R. 5539 S. 476 S.3131